Regulation
-
DEA Plans Schedule I Order for Two Kratom Compounds Above Threshold
The Drug Enforcement Administration published a notice of intent on October 14, 2026, announcing that it will issue a temporary order placing two kratom-related substances, 7-hydroxymitragynine and mitragynine pseudoindoxyl, in Schedule I of the Controlled Substances Act whenever either substance…
-
Do Legal Cannabis Stores Increase Nearby Crime?
When a cannabis store opens, neighbourhood concerns often arrive before its first customers. Residents may worry about theft, intoxication, or whether a once-quiet commercial strip will become less safe. These are understandable questions, but answering them requires more than comparing…
-
DEA Denies MedPharm Research Bid for Bulk Marijuana Manufacturing
The Drug Enforcement Administration has denied the application of MedPharm Research, LLC, of Denver, Colorado, for registration as a bulk manufacturer of marijuana in its Schedule I form, granting the Government’s Request for Final Agency Action after the company did…
-
Why Cannabis Laws and Cannabis Science Differ
Cannabis can be described as a drug, a medicine, a controlled substance, or a consumer product. Those labels often appear to compete with one another, as though choosing one settles what the plant is and how society should treat it.…
-
DEA Revokes Registration of Texas Pharmacy Over Opioid Red Flags
The Drug Enforcement Administration has revoked the federal controlled-substance registration of St. Michael’s Pharmacy of Rosenberg, Texas, in a Decision and Order published in the Federal Register on October 2, 2026, after the pharmacy defaulted on allegations that it repeatedly…
-
Curaleaf International’s Que Cannabis Inhaler Registered in Australia
Curaleaf International, part of Curaleaf Holdings, Inc. , in partnership with Jupiter Research LLC, said in an announcement issued through PR Newswire on 2 October 2026 that its Que Medical Inhalation Device (QMID) is available in Australia following registration by…
-
Maryland Cannabis Administration to Launch Five-Lab Testing Accuracy Pilot
The Maryland Cannabis Administration announced on September 28, 2026, that it will launch a proficiency testing pilot in October 2026 comparing cannabinoid testing of Maryland-licensed cannabis flower across five laboratories. In the release, issued from Linthicum, Maryland, the agency described…
-
Massachusetts Cannabis Commission Takes Comments on Agent Badge Rules
The Massachusetts Cannabis Control Commission on September 28, 2026, opened an informal public comment period on potential regulatory changes to the registration requirements for Registered Agents of licensed Marijuana Establishments and Medical Marijuana Establishments. Stakeholders may submit written comments through…
-
Massachusetts Cannabis Bulletin Keeps Online Discount Ads Prohibited
The Massachusetts Cannabis Control Commission’s Investigations and Enforcement Department on September 25, 2026 issued a bulletin to all licensed Marijuana Establishments, clarifying that Chapter 65 of the Acts of 2026 did not extend advertising or discounting allowances to licensee websites…
-
Michigan Cannabis Regulator Unveils August Disciplinary And Denial Reports
The Michigan Cannabis Regulatory Agency published its August 2026 Disciplinary Action Report and a new Denied Application and Non-Renewed License Report on September 25, 2026, making final licensing denials, non-renewals, administrative formal complaints, and disciplinary actions taken against adult-use and…
-
How CBD Regulations Shape What Consumers Buy and Why
CBD may be the same molecule from one country to another, but consumers do not encounter it in the same way. In Canada, it is regulated as cannabis and sold through authorized cannabis channels. In Australia and Aotearoa New Zealand,…
-
Aurora Cannabis Asks Alberta Regulator to Order Curaleaf Bid Changes
Aurora Cannabis Inc. announced on September 23, 2026 that it has filed an application with the Alberta Securities Commission seeking an order requiring Curaleaf Holdings, Inc. to correct several deficiencies Aurora says it identified in Curaleaf’s hostile bid circular and…
-
Missouri Supreme Court Hears Fight Over 13 Medical Marijuana Licenses
The Missouri Supreme Court heard oral argument on September 23, 2026, in Hippos, LLC v. Missouri Department of Health and Senior Services, with the state seeking to preserve its denial of 13 medical marijuana facility licenses after an appeals court…
-
Why Flavor-Named Cannabis Sells More to Young Adults
A cannabis product name can suggest genetics, aroma, taste, effects, or little more than an attractive marketing concept. New sales research indicates those names may also be closely associated with who buys the product.A study published in the International Journal…
-
Why Cannabis Research Still Lags Behind the Science
Scientists have spent more than three decades mapping the endocannabinoid system, yet physicians still lack high-quality evidence for many potential cannabinoid treatments. This mismatch is often summarized by saying cannabis needs more research. That is true, but it leaves out…
